Search

everythinglearnresearchcommunity

for

Search:↓

Regulatory T cells help heal skin and grow hair, and their absence can lead to healing issues and hair loss.

FGF21 can help reduce skin inflammation caused by C. acnes.

Blocking EGFR in skin cells doesn't majorly increase inflammation markers.

DHT may reduce inflammation caused by certain bacteria in skin cells.

Erdr1 could be a new marker for diagnosing hair loss.

Acne is linked to inflammation and insulin resistance, and is associated with various syndromes that require different treatments.

Cicatricial alopecia, a permanent hair loss condition, is mainly caused by damage to specific hair follicle stem cells and abnormal immune responses, with gene regulator PPAR-y and lipid metabolism disorders playing significant roles.

The conclusion is that primary scarring alopecia is a complex condition that requires early and accurate diagnosis for effective treatment.

Non-invasive methods show promise for diagnosing skin diseases like psoriasis and lupus but need more research for regular use.

New treatments and diagnostic methods for various animal skin conditions showed promising results.

The document concludes that more research is needed to better understand and treat primary cicatricial alopecias, and suggests a possible reclassification based on molecular pathways.

UVB is good for a skin condition in Asian kids, a lotion works for head lice, a drug helps with a skin blistering disorder, a foam reduces itchiness in skin inflammation, birthmarks can be more widespread, and criteria for a neurocutaneous disorder were agreed upon.

Early recognition and management of skin side effects from new cancer therapies can prevent treatment delays.

Enzymes called PADIs play a key role in hair growth and loss.

EGFR inhibitors often cause skin problems and other side effects, but these are usually reversible and can be managed to keep patients comfortable.

The document concludes that better targeted treatments are needed for wound healing, and single-cell technologies may improve cell-based therapies.

The symposium concluded that a specific lipid might cause hair loss, inflammation is a key factor, and stem cells in bald scalps aren't working right, suggesting new treatment targets.

Colchicine might help treat different skin diseases, but more research is needed to confirm its effectiveness and safe dosage.

Psoriasis involves immune and genetic factors, and understanding these can improve treatments.

New chemotherapy drugs cause skin side effects, but treatments like minocycline and tetracycline can help reduce them.

Some drugs, especially biologics, can cause skin reactions that look like other skin diseases, and stopping the drug usually helps clear up these reactions.

MALDI Imaging Mass Spectrometry is a useful method for studying skin conditions, but sample preparation is crucial for accurate results.

There are still challenges in diagnosing and treating chronic skin diseases, but there is hope for future improvements.

A woman with lupus had unusual symptoms like blisters, skin inflammation, and throat ulcers, which improved with steroid and dapsone treatment.

JAK inhibitors help with skin conditions but need more research on dosing and safety.

The document is a detailed medical reference on skin and genetic disorders.

JAK inhibitors show promise for treating skin conditions like eczema, hair loss, and psoriasis.

Old drugs like finasteride and spironolactone are being successfully used for hair loss and skin conditions, and many other drugs show promise for new uses in dermatology.

A chemical called 5-Bromo-2′-deoxyuridine caused rapid hair loss in mice by killing certain skin cells through a specific cell death pathway.

The document concludes that recognizing and treating cutaneous lupus erythematosus early is crucial for managing the skin and potential systemic symptoms.